Issuer (NYSE: NXRT) insider files to sell 8,452 common shares under Rule 144
Rhea-AI Filing Summary
NexPoint Residential Trust insider files to sell shares under Rule 144. A holder plans to sell up to 8,452 shares of common stock through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $239,867 based on the figures provided. The issuer reports 25,364,470 common shares outstanding, and the planned sale date is around 12/19/2025.
The shares to be sold were acquired as compensation through restricted stock unit (RSU) vesting on several dates in 2024 and 2025. The same person previously sold 5,000 common shares on 10/31/2025 for gross proceeds of $152,600. By signing the notice, the seller represents that they are not aware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
FAQ
What does the Form 144 filing for NXRT disclose?
The filing discloses that a holder intends to sell up to 8,452 shares of NexPoint Residential Trust common stock under Rule 144, with an aggregate market value of $239,867, through J.P. Morgan Securities LLC on the NYSE.
How many NexPoint Residential Trust (NXRT) shares are planned for sale and at what value?
The notice covers a proposed sale of 8,452 common shares of NexPoint Residential Trust, with an indicated aggregate market value of $239,867.
How were the NXRT shares in this Form 144 acquired?
The shares to be sold were acquired via RSU vesting from the issuer on several dates in 2024 and 2025, and are described as compensation.
What prior NXRT share sales by this person are reported in the last 3 months?
The person previously sold 5,000 NexPoint Residential Trust common shares on 10/31/2025, generating gross proceeds of $152,600.
How many NexPoint Residential Trust (NXRT) shares are outstanding in this filing?
The filing states that there are 25,364,470 common shares of NexPoint Residential Trust outstanding.
What representation does the seller make in this NXRT Form 144 notice?
By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.